Peptisyntha Announces Successful FDA Inspection

Mar 02, 2015
Peptisyntha, a CordenPharma facility near Brussels, Belgium, announces a successful completion of their recent FDA inspection.


Peptisyntha has built a 26 year track record of success in supplying pharmaceutical and biotech companies with small to commercial scale cGMP peptide APIs using a portfolio of innovative proprietary technologies with the objective to shorten synthetic processes / reduce the number of steps, control quality, and simplify HPLC purifications for short peptides. Peptisyntha has received a total of 6 successful inspections by the FDA.